Biotech Investors & VC Firms in North America

1595 firms in this list, with a median first check of $500K. 348 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
BI Bioscience Equity Partners GS1 person	88🔒	Dubai	AE	Late Stage	—	+ Add to CRM
NI Nissay Capital NA1 person	88🔒	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
SA Salt Mines Advisors TC1 person	88🔒	—		Pre-Seed–Series A	—	+ Add to CRM
ST Stonebridge Ventures HKDCSW3 people	88🔒	Seoul	KR	Series A–Series C	—	+ Add to CRM
EG Egora Holding	88🔒	Martinsried	DE	Seed–Series B	$5.4M	+ Add to CRM
MA Mankind Pharma	88🔒	New Delhi	IN	Series A	—	+ Add to CRM
VE VentureTECH	88🔒	Selangor	MY	Series A	—	+ Add to CRM
IM IMM Investment	88🔒	Kangnam	KR	Pre-Seed–Growth	—	+ Add to CRM
RM RMGP Biopharma Investment Fund AKBRTMYB6 people	88🔒	Herzliya	IL	Seed–Series A	—	+ Add to CRM
DA Dauntless VC	88🔒	—		Seed	—	+ Add to CRM
QF QF Capital	88🔒	Shenzhen	CN	Pre-Seed–Series A	—	+ Add to CRM
SK SK Venture Partners	88🔒	London	GB	Pre-Seed–Seed	—	+ Add to CRM
OC Oceanpine Capital DCDMJJRY5 people	88🔒	Beijing	CN	Series A–Late Stage	—	+ Add to CRM
ES Esperante Ventures DS1 person	88🔒	London	GB	Seed–Series A	$540K – $5.4M	+ Add to CRM
MO Morningside Group KS1 person	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
JA Japan Asia Investment SM1 person	88🔒	Tokyo	JP	Pre-Seed–Late Stage	$1M – $10M	+ Add to CRM
CO Company K Partners	88🔒	Seoul	KR	Series A–Series B	—	+ Add to CRM
BR Brandon Capital Partners CS1 person	88🔒	Melbourne	AU	Seed–Growth	—	+ Add to CRM
VE Vesper Ventures SA Follows rounds	88🔒	—		Pre-Seed–Seed	$100K – $5M	+ Add to CRM
OR Oriza Holdings	88🔒	Suzhou	CN	Seed–Series C	—	+ Add to CRM
EA East Gate Partners ELSS2 people	88🔒	Seoul	KR	Seed–Series A	—	+ Add to CRM
GL Global Venture Capital, Inc. HHMJ2 people	88🔒	Tokyo	JP	Seed–Series A	—	+ Add to CRM
CD CDIB Capital	88🔒	Hong Kong	HK	Series A–Series C	—	+ Add to CRM
IB IBK Capital	88🔒	Seoul	KR	Seed–Series B	—	+ Add to CRM

Bioscience Equity Partners

DubaiLate Stage

GS1 person

Nissay Capital

TokyoPre-Seed–Growth

NA1 person

Salt Mines Advisors

Pre-Seed–Series A

TC1 person

Stonebridge Ventures

SeoulSeries A–Series C

HKDCSW3 people

Egora Holding

MartinsriedSeed–Series B$5.4M

Mankind Pharma

New DelhiSeries A

VentureTECH

SelangorSeries A

IMM Investment

KangnamPre-Seed–Growth

RMGP Biopharma Investment Fund

HerzliyaSeed–Series A

AKBRTMYB6 people

Dauntless VC

Seed

QF Capital

ShenzhenPre-Seed–Series A

SK Venture Partners

LondonPre-Seed–Seed

Oceanpine Capital

BeijingSeries A–Late Stage

DCDMJJRY5 people

Esperante Ventures

LondonSeed–Series A$540K – $5.4M

DS1 person

Morningside Group

Hong KongSeed–Growth

KS1 person

Japan Asia Investment

TokyoPre-Seed–Late Stage$1M – $10M

SM1 person

Company K Partners

SeoulSeries A–Series B

Brandon Capital Partners

MelbourneSeed–Growth

CS1 person

Vesper Ventures SA

Pre-Seed–Seed$100K – $5M

Oriza Holdings

SuzhouSeed–Series C

East Gate Partners

SeoulSeed–Series A

ELSS2 people

Global Venture Capital, Inc.

TokyoSeed–Series A

HHMJ2 people

CDIB Capital

Hong KongSeries A–Series C

IBK Capital

SeoulSeed–Series B

Data sourced from public filings and firms' own websites — see our methodology.